loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

Approved Drug Products containing 208065 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ASTRAZENECA (2)

filter

01 TABLET;ORAL (2)

filter

01 RX (2)

filter

01 TAGRISSO (2)

filter

01 Yes (2)

URL Supplier Web Content
TABLET; ORAL
EQ 80MG BASE
2015-11-13
208065
TAGRISSO
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
EQ 40MG BASE
2015-11-13
208065
TAGRISSO
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 208065

Looking for FDA Orange Book APPLICATION 208065 2

19

AstraZeneca, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is OSIMERTINIB MESYLATE, with a corresponding application number 208065.

Regulatory Information RX

With a dosage strength EQ 80MG BASE

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2015-11-13

18

AstraZeneca, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is OSIMERTINIB MESYLATE, with a corresponding application number 208065.

Regulatory Information RX

With a dosage strength EQ 40MG BASE

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2015-11-13

Post Enquiry
POST ENQUIRY